Direct-to-consumer advertising in oncology

Oncologist

Volumn 11, Issue 2, 2006, Pages 217-226

  Abel, Gregory A ^b   Penson, Richard T ^a   Joffe, Steven ^b   Schapira, Lidia ^b   Chabner, Bruce A ^b   Lynch Jr , Thomas J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Cancer; Communication; Connection; Personal; Psychosocial; Support

Indexed keywords

ALENDRONIC ACID; APREPITANT; ARMIDEX; CAPECITABINE; CETUXIMAB; CYCLOSPORIN A; DOCETAXEL; ERLOTINIB; ETANERCEPT; GEMCITABINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INFLIXIMAB; LETROZOLE; MACROGOL 3350; ONDANSETRON; PALONOSETRON; PAROXETINE; PEMETREXED; PNEUMOCOCCUS VACCINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ROFECOXIB; TOSITUMOMAB I 131; TRASTUZUMAB; UNINDEXED DRUG; VARDENAFIL; ZOLEDRONIC ACID;

CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVOR; CANCER THERAPY; CAREGIVER; CLINICAL PRACTICE; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HUMAN; MASS COMMUNICATION; MEDICAL ETHICS; MEDICAL LITERATURE; NON PROFIT ORGANIZATION; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY;

ACADEMIC MEDICAL CENTERS; ADVERTISING; ANTINEOPLASTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; BOSTON; COMMUNICATION; DRUG INDUSTRY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 32944471556     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.11-2-217     Document Type: Review

References (34)

1. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 2000;19:110-128.
2. Melillo W. Drug companies work to stave off legislation. Adweek, July 11, 2005.
3. Lenzer J. FDA investigates direct to consumer adverts. BMJ 2005;331:1102.
4. Behrman RE. The Impact of Direct-to-Consumer Drug Advertising on Seniors' Health and Health Care Costs. Testimony Before the Senate Special Committee on Aging. United States Senate, September 29, 2005. Available at http://aging.senate.gov/public/_files/hr148rb.pdf. Accessed December 15, 2005.
5. Fintor L. Direct-to-consumer marketing: how has it fared? J Natl Cancer Inst 2002;94:329-331.
6. Saul S. Drug makers to police consumer campaigns. The New York Times, August 3, 2005:7.
7. Macilwain C. Drug firms back-pedal on direct advertising. Nature 2005;436:910-911.
8. CURE Magazine Media Kit. Available at http://www.curetoday.com/ advertising/documents/mediakit_11.14.05.pdf. Accessed December 15, 2005.
9. Lyles A. Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health 2002;23:73-91.
10. U.S. Department of Health and Human Services. Guidance for Industry. Consumer-Directed Broadcast Advertisements. August 1999. Available at http://www.fda.gov/cder/guidance/1804fnl.pdf. Accessed December 15, 2005.
11. Rosenthal MB, Berndt ER, Donohue JM et al. Promotion of prescription drugs to consumers. N Engl J Med 2002;346:498-505.
12. Aiken K, Swassy J, Braman A. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs-Summary of FDA Survey Research Results. Appendix B.3. 2002 Physician Survey. Available at http://www.fda.gov/cder/ddmac/Final%20Report/DTCPhysicianSurvey%20Materialsb3. pdf. Accessed December 15, 2005.
13. Murray E, Lo B, Pollack L et al. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract 2004;17:6-18.
14. Robinson AR, Hohmann KB, Rifkin JI et al. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 2004;164:427-432.
15. Weissman JS, Blumenthal D, Silk AJ et al. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood) 2003;(suppl web exclusives):W3-82-W3-95.
16. Weissman JS, Blumenthal D, Silk AJ et al. Physician reports on patient encounters involving direct-to-consumer drug advertising. Health Aff (Millwood) 2004;(suppl web exclusives):W4-219-W4-233.
17. Avorn J. Advertising and prescription drugs: promotion, education, and the public's health. Health Aff (Millwood) 2003;(suppl web exclusives): W3-104-W3-108.
18. Dubois RW. Pharmaceutical promotion: don't throw the baby out with the bathwater. Health Aff (Millwood) 2003;(suppl web exclusives):W3-96-W3-103.
19. Viale PH, Sanchez Yamamoto D. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncol Nurs Forum 2004;31:777-783.
20. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med 1999;14:651-657.
21. Peyrot M, Alperstein NM, Van Doren D et al. Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests. Mark Health Serv 1998;18:26-32.
22. Sumpradit N, Fors SW, McCormick L. Consumers' attitudes and behavior toward prescription drug advertising. Am J Health Behav 2002;26:68-75.
23. Centers for Disease Control and Prevention (CDC). Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing - Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep 2004;53:603-606.
24. Gray S, Olopade OI. Direct-to-consumer marketing of genetic tests for cancer: buyer beware. J Clin Oncol 2003;21:3191-3193.
25. Mintzes B, Barer ML, Kravitz RL et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003;169:405-412.
26. Zachry WM 3rd, Dalen JE, Jackson TR. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med 2003;163:1808-1812.
27. Kravitz RL, Epstein RM, Feldman MD et al. Inf luence of patient's requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005;293:1995-2002.
28. Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005;293:2030-2033.
29. U.S. Department of Health and Human Services. Guidance for Industry. Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements. Draft Guidance, January, 2004. Available at http://www.fda.gov/ cder/guidance/5669dft.pdf. Accessed December 15, 2005.
30. U.S. Department of Health and Human Services. Draft Guidance for Industry and FDA. Consumer-Directed Broadcast Advertising on Restricted Devices. Draft Guidance - Issued 2/10/04. Available at http://www.fda.gov/cdrh/comp/guidance/ 1513.pdf. Accessed December 15, 2005.
31. U.S. Department of Health and Human Services. Guidance for Industry. "Help-Seeking" and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms. Draft Guidance, January 2004. Available at: http://www.fda.gov/cder/guidance/6019dft.doc. Accessed December 15, 2005.
32. Berndt ER. To inform or persuade? Direct-to-consumer advertising of prescription drugs. N Engl J Med 2005;352:325-328.
33. PhRMA Guiding Principles: Direct to Consumer Advertisements About Prescription Medicines. Available at http://www.phrma.org/publications/policy// 2005-11-29.1194.pdf. Accessed December 15, 2005.
34. Vastag B. FDA considers tightening regulations for direct-to-consumer advertising. J Natl Cancer Inst 2005;97:1806-1807.